Table: Towa Pharmaceutical -Q1 group results

TOWA PHARMACEUTICAL

06/08/2026 07:35

    Aug 6 (Reuters)- 
             Towa Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2026        Jun 30, 2025     Mar 31, 2027 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             71.38               65.15           304.00    
                 (+9.6 pct)          (+4.1 pct)       (+11.1 pct) 
  Operating          6.52                5.21            32.00    
                 (+25.2 pct)         (-8.2 pct)       (+38.5 pct) 
  Recurring          7.94                3.95            30.00    
                (+100.9 pct)         (-54.0 pct)      (+6.8 pct)  
  Net                5.53                2.51            21.50    
                (+120.1 pct)         (-54.3 pct)     (+309.5 pct) 
  EPS            112.36 yen           51.06 yen       430.77 yen  
  Ann Div                             80.00 yen        85.00 yen  
  -Q2 div                             40.00 yen        40.00 yen  
  -Q4 div                             40.00 yen        45.00 yen  
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T